Gregory D Davis insider trades
Open-market stock purchases and sales by Gregory D Davis, Head of Research & Technology at Sangamo Therapeutics, Inc, from SEC Form 4 filings since Nov 24, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 25, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $284 |
| Apr 22, 2026 | SGMO Sangamo Therapeutics, Inc | Sold | $17.7K |
| Apr 1, 2026 | SGMO Sangamo Therapeutics, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $2.4K |
| Feb 24, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $393 |
| Jan 22, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $3.1K |
| Nov 24, 2025 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $301 |
| Oct 22, 2025 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $4.4K |
Companies traded
- SGMO Sangamo Therapeutics, Inc: 1 sale, last May 25, 2026